ALTEOGEN Market Cap

ALTEOGEN has a market cap or net worth of 22.55 trillion as of August 22, 2025. Its market cap has increased by 48.95% in one year.

Market Cap

22.55T

Enterprise Value

22.30T

Revenue

158.06B

Ranking

n/a

PE Ratio

260.92

Stock Price

422,000.00

Market Cap Chart

Since December 12, 2014, ALTEOGEN's market cap has increased from 119.96B to 22.55T, an increase of 18,700.46%. That is a compound annual growth rate of 63.14%.

Market Cap History

Date	Market Cap	% Change
Aug 21, 2025	21.67T	31.38%
Dec 30, 2024	16.49T	221.05%
Dec 28, 2023	5,137.84B	160.78%
Dec 29, 2022	1,970.17B	-38.41%
Dec 30, 2021	3,198.72B	-36.62%
Dec 30, 2020	5,046.50B	442.81%
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro
Dec 30, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	72.53T
Celltrion	37.92T
Yuhan	8,477.94B
SK Biopharmaceuticals	7,596.39B
Peptron	7,478.45B
PharmaResearch	7,064.96B
HLB Co., Ltd.	5,168.61B
LigaChem Biosciences	5,115.17B

Market Cap Rankings